These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 31417241)

  • 1. Impact of different emulsifiers on biocompatibility and inflammatory potential of Perfluorohexyloctane (F6H8) emulsions for new intravenous drug delivery systems.
    Tsagogiorgas C; Anger F; Beck G; Breedijk A; Yard B; Hoeger S
    Drug Des Devel Ther; 2019; 13():2097-2110. PubMed ID: 31417241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of pharmacokinetic properties and anaesthetic effects of propofol in a new perfluorohexyloctane (F6H8) emulsion in rats--A comparative study.
    Tsagogiorgas C; Theisinger S; Heesch E; Krebs J; Holm R; Beck G; Yard B
    Int J Pharm; 2015; 486(1-2):69-76. PubMed ID: 25797054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence on membrane-mediated cell activation by vesicles of silicone oil or perfluorohexyloctane.
    Kociok N; Gavranic C; Kirchhof B; Joussen AM
    Graefes Arch Clin Exp Ophthalmol; 2005 Apr; 243(4):345-58. PubMed ID: 15864624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Semifluorinated alkanes--a new class of excipients suitable for pulmonary drug delivery.
    Tsagogiorgas C; Krebs J; Pukelsheim M; Beck G; Yard B; Theisinger B; Quintel M; Luecke T
    Eur J Pharm Biopharm; 2010 Sep; 76(1):75-82. PubMed ID: 20685332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Semifluorinated alkane based systems for enhanced corneal penetration of poorly soluble drugs.
    Agarwal P; Scherer D; Günther B; Rupenthal ID
    Int J Pharm; 2018 Mar; 538(1-2):119-129. PubMed ID: 29339249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined use of perfluorohexyloctane and silicone oil as intraocular tamponade: an in vitro study.
    Lepori L; Matteoli E; Spanedda A; Genovesi-Ebert F; Rizzo S
    Graefes Arch Clin Exp Ophthalmol; 2006 Jan; 244(1):79-82. PubMed ID: 15983813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel excipient, 1-perfluorohexyloctane shows limited utility for the oral delivery of poorly water-soluble drugs.
    Holm R; Jørgensen EB; Harborg M; Larsen R; Holm P; Müllertz A; Jacobsen J
    Eur J Pharm Sci; 2011 Mar; 42(4):416-22. PubMed ID: 21256961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formation and stability of emulsions stabilized by Quillaja saponin-egg lecithin mixtures.
    Salminen H; Bischoff S; Weiss J
    J Food Sci; 2020 Apr; 85(4):1213-1222. PubMed ID: 32249411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro evaluation of lysophosphatidic acid delivery via reverse perfluorocarbon emulsions to enhance alveolar epithelial repair.
    Nelson DL; Zhao Y; Fabiilli ML; Cook KE
    Colloids Surf B Biointerfaces; 2018 Sep; 169():411-417. PubMed ID: 29807339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physicochemical characterization and acute toxicity evaluation of a positively-charged submicron emulsion vehicle.
    Klang SH; Frucht-Pery J; Hoffman A; Benita S
    J Pharm Pharmacol; 1994 Dec; 46(12):986-93. PubMed ID: 7714723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving emulsification efficacy of lecithin by formulation design. I: Effect of adding a secondary surfactant.
    Krishna G; Wood GC; Sheth BB
    PDA J Pharm Sci Technol; 1998; 52(6):331-6. PubMed ID: 10050132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perfluorohexyloctane (F
    Chachaj-Brekiesz A; Wnętrzak A; Lipiec E; Kobierski J; Dynarowicz-Latka P
    Colloids Surf B Biointerfaces; 2019 Dec; 184():110564. PubMed ID: 31704647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of antioxidant properties of lecithin emulsifier on oxidative stability of encapsulated bioactive compounds.
    Pan Y; Tikekar RV; Nitin N
    Int J Pharm; 2013 Jun; 450(1-2):129-37. PubMed ID: 23618963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and properties of a stable intravenous lorazepam emulsion.
    Yalin M; Oner F; Oner L; Hincal AA
    J Clin Pharm Ther; 1997 Feb; 22(1):39-44. PubMed ID: 9292401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interfacial properties as stability predictors of lecithin-stabilized perfluorocarbon emulsions.
    Yoon JK; Burgess DJ
    Pharm Dev Technol; 1996 Dec; 1(4):333-41. PubMed ID: 9552317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of the interface of edible nanoemulsions to modulate the bioaccessibility of neuroprotective antioxidants.
    Plaza-Oliver M; Baranda JF; Rodríguez Robledo V; Castro-Vázquez L; Gonzalez-Fuentes J; Marcos P; Lozano MV; Santander-Ortega MJ; Arroyo-Jimenez MM
    Int J Pharm; 2015 Jul; 490(1-2):209-18. PubMed ID: 25997659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Raw and salt-processed Achyranthes bidentata attenuate LPS-induced acute kidney injury by inhibiting ROS and apoptosis via an estrogen-like pathway.
    Wang S; Zeng M; Li B; Kan Y; Zhang B; Zheng X; Feng W
    Biomed Pharmacother; 2020 Sep; 129():110403. PubMed ID: 32574970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further evidence for proinflammatory nature of perfluorohexyloctane in the eye.
    Vote B; Wheen L; Cluroe A; Teoh H; McGeorge A
    Clin Exp Ophthalmol; 2003 Oct; 31(5):408-14. PubMed ID: 14516428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naproxen incorporated lipid emulsions. I. Formulation and stability studies.
    Nasirideen S; Kaş HS; Oner F; Alpar R; Hincal AA
    J Clin Pharm Ther; 1998 Feb; 23(1):57-65. PubMed ID: 9756113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence of toxic side effects of perfluorohexyloctane after vitreoretinal surgery as well as in previously established in vitro models with ocular cell types.
    Mertens S; Bednarz J; Engelmann K
    Graefes Arch Clin Exp Ophthalmol; 2002 Dec; 240(12):989-95. PubMed ID: 12483321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.